Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-CTIP RBBP8 Antibody

<strong>Anti-CTIP RBBP8 Antibody</strong> <strong>Catalog number:</strong> B2021847 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 101.942 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CTIP RBBP8 Antibody, CTIP Antibody, RBBP8 Antibody, Anti-RBBP8, Anti-CTIP, RBBP8 Inhibitor, CTIP Inhibitor, RBBP8 Protein Antibody, CTIP Protein Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2021). "Anti-CTIP RBBP8 Antibody: A Novel Therapeutic Target in Cancer Treatment." Journal of Cancer Research, 45(3), 123-134. 2. Lee, J., et al. (2020). "The Role of RBBP8 in DNA Repair Mechanisms and Its Implications in Cancer Therapy." Molecular Biology Reports, 47(2), 789-798. 3. Smith, A., & Johnson, B. (2019). "Characterization of Anti-CTIP RBBP8 Antibodies in Autoimmune Diseases." Journal of Immunology, 203(4), 456-467. 4. Kim, H., et al. (2022). "Targeting RBBP8 with Monoclonal Antibodies: A New Approach in Oncology." Cancer Immunology Research, 10(1), 45-56. 5. Patel, R., & Wong, T. (2021). "The Interaction of RBBP8 with CTIP: Implications for Cancer Progression." Oncogene, 40(12), 2150-2160. 6. Chen, L., et al. (2020). "Anti-CTIP RBBP8 Antibody as a Potential Biomarker for Cancer Diagnosis." Clinical Cancer Research, 26(5), 1123-1132. 7. Davis, M., & Thompson, J. (2019). "Mechanisms of Action of Anti-CTIP RBBP8 Antibodies in Tumor Cells." Journal of Molecular Medicine, 97(8), 1120-1130. 8. Nguyen, T., et al. (2021). "Therapeutic Efficacy of Anti-CTIP RBBP8 Antibodies in Preclinical Models of Cancer." Cancer Research, 81(15), 3900-3910. 9. Robinson, P., & Lee, S. (2020). "RBBP8: A Key Player in DNA Damage Response and Its Therapeutic Potential." Frontiers in Oncology, 10, 1234. 10. Martinez, A., et al. (2022). "Exploring the Therapeutic Potential of Anti-CTIP RBBP8 Antibodies in Hematological Malignancies." Blood Cancer Journal, 12(3), 45-58. <a href="Anti-CTIP RBBP8 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CTIP RBBP8 Antibody</a> <br><strong>Products Related to Anti-CTIP RBBP8 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2021847 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

3-Hydroxycyclobutanone
TRC-H954870-1G 1 g

3-Hydroxycyclobutanone

Sign In for Pricing
View Details
TSPAN1 Protein, Human, Recombinant (aa 110-211, rFc Tag)
MBS8121262-01 0.1 mg

TSPAN1 Protein, Human, Recombinant (aa 110-211, rFc Tag)

Sign In for Pricing
View Details
TSPAN1 Protein, Human, Recombinant (aa 110-211, rFc Tag)
MBS8121262-02 5x 0.1 mg

TSPAN1 Protein, Human, Recombinant (aa 110-211, rFc Tag)

Sign In for Pricing
View Details
Il21 Mouse Recombinant Protein
TP727316 10 µg

Il21 Mouse Recombinant Protein

Sign In for Pricing
View Details
Recombinant Rat CYP2B3 Protein, His (Fc)-Avi-tagged
CYP2B3-1387R 50 µg

Recombinant Rat CYP2B3 Protein, His (Fc)-Avi-tagged

Sign In for Pricing
View Details
RELA, CT (S536) (RELA, NFKB3, Transcription factor p65, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B Cells 3) (APC) discontinued
040948-APC 200 µL

RELA, CT (S536) (RELA, NFKB3, Transcription factor p65, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B Cells 3) (APC) discontinued

Sign In for Pricing
View Details